155 related articles for article (PubMed ID: 22267483)
1. Identification of galectin-1 and galectin-3 as novel partners for von Willebrand factor.
Saint-Lu N; Oortwijn BD; Pegon JN; Odouard S; Christophe OD; de Groot PG; Denis CV; Lenting PJ
Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):894-901. PubMed ID: 22267483
[TBL] [Abstract][Full Text] [Related]
2. Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand disease.
De Meyer SF; Vandeputte N; Pareyn I; Petrus I; Lenting PJ; Chuah MK; VandenDriessche T; Deckmyn H; Vanhoorelbeke K
Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1621-6. PubMed ID: 18556568
[TBL] [Abstract][Full Text] [Related]
3. Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-Inflammation.
Dhanesha N; Prakash P; Doddapattar P; Khanna I; Pollpeter MJ; Nayak MK; Staber JM; Chauhan AK
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1829-37. PubMed ID: 27444201
[TBL] [Abstract][Full Text] [Related]
4. Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A/M1606A and R1597W.
Pruss CM; Golder M; Bryant A; Hegadorn C; Haberichter S; Lillicrap D
J Thromb Haemost; 2012 May; 10(5):940-50. PubMed ID: 22372972
[TBL] [Abstract][Full Text] [Related]
5. A new animal model of thrombophilia confirms that high plasma factor VIII levels are thrombogenic.
Kawasaki T; Kaida T; Arnout J; Vermylen J; Hoylaerts MF
Thromb Haemost; 1999 Feb; 81(2):306-11. PubMed ID: 10064011
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the von Willebrand factor with platelets and thrombosis.
Perutelli P; Mori PG
Recenti Prog Med; 1997 Nov; 88(11):526-9. PubMed ID: 9401429
[TBL] [Abstract][Full Text] [Related]
7. Mouse models to study von Willebrand factor structure-function relationships in vivo.
Denis CV; Marx I; Badirou I; Pendu R; Christophe O
Hamostaseologie; 2009 Jan; 29(1):17-8, 20. PubMed ID: 19151840
[TBL] [Abstract][Full Text] [Related]
8. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor.
Hoylaerts MF
Verh K Acad Geneeskd Belg; 1997; 59(3):161-83. PubMed ID: 9490916
[TBL] [Abstract][Full Text] [Related]
9. Binding of von Willebrand factor to collagen and glycoprotein Ibalpha, but not to glycoprotein IIb/IIIa, contributes to ischemic stroke in mice--brief report.
De Meyer SF; Schwarz T; Deckmyn H; Denis CV; Nieswandt B; Stoll G; Vanhoorelbeke K; Kleinschnitz C
Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):1949-51. PubMed ID: 20616311
[TBL] [Abstract][Full Text] [Related]
10. Correction of bleeding symptoms in von Willebrand factor-deficient mice by liver-expressed von Willebrand factor mutants.
Marx I; Lenting PJ; Adler T; Pendu R; Christophe OD; Denis CV
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):419-24. PubMed ID: 18187670
[TBL] [Abstract][Full Text] [Related]
11. Structure and function of von Willebrand factor.
Hassan MI; Saxena A; Ahmad F
Blood Coagul Fibrinolysis; 2012 Jan; 23(1):11-22. PubMed ID: 22089939
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
[TBL] [Abstract][Full Text] [Related]
13. Regulation of von Willebrand factor-platelet interactions.
Lenting PJ; Pegon JN; Groot E; de Groot PG
Thromb Haemost; 2010 Sep; 104(3):449-55. PubMed ID: 20539912
[TBL] [Abstract][Full Text] [Related]
14. Interventional thermal injury of the arterial wall: unfolding of von Willebrand factor and its increased binding to collagen after 55 degrees C heating.
Post MJ; de Graaf-Bos AN; Posthuma G; de Groot PG; Sixma JJ; Borst C
Thromb Haemost; 1996 Mar; 75(3):515-9. PubMed ID: 8701418
[TBL] [Abstract][Full Text] [Related]
15. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
[TBL] [Abstract][Full Text] [Related]
16. O-linked glycosylation and functional incompatibility of porcine von Willebrand factor for human platelet GPIb receptors.
Schulte Am Esch J; Robson SC; Knoefel WT; Hosch SB; Rogiers X
Xenotransplantation; 2005 Jan; 12(1):30-7. PubMed ID: 15598271
[TBL] [Abstract][Full Text] [Related]
17. [Von Willebrand factor and platelet adhesion to the subendothelium of the vascular wall].
Meyer D
Nouv Rev Fr Hematol (1978); 1982; 24(3):145-51. PubMed ID: 6752879
[TBL] [Abstract][Full Text] [Related]
18. Recombinant von Willebrand factor-insight into structure and function through infusion studies in animals with severe von Willebrand disease.
Schwarz HP; Schlokat U; Mitterer A; Váradi K; Gritsch H; Muchitsch EM; Auer W; Pichler L; Dorner F; Turecek PL
Semin Thromb Hemost; 2002 Apr; 28(2):215-26. PubMed ID: 11992244
[TBL] [Abstract][Full Text] [Related]
19. Osteoprotegerin (OPG) is localized to the Weibel-Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor.
Zannettino AC; Holding CA; Diamond P; Atkins GJ; Kostakis P; Farrugia A; Gamble J; To LB; Findlay DM; Haynes DR
J Cell Physiol; 2005 Aug; 204(2):714-23. PubMed ID: 15799029
[TBL] [Abstract][Full Text] [Related]
20. Endothelial PTP1B Deletion Promotes VWF Exocytosis and Venous Thromboinflammation.
Zifkos K; Bochenek ML; Gogiraju R; Robert S; Pedrosa D; Kiouptsi K; Moiko K; Wagner M; Mahfoud F; Poncelet P; Münzel T; Ruf W; Reinhardt C; Panicot-Dubois L; Dubois C; Schäfer K
Circ Res; 2024 May; 134(10):e93-e111. PubMed ID: 38563147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]